On 5 February 2017, 340 million shares of the Barakat Pharmaceutical Group were first Released on the Tehran Stock Exchange in the Group of Pharmaceutical Materials and Products.[13] By this date, 50% of the company's shareholders were natural people.[14] According to Baqerinezhad, the company's research and development deputy, 800 billion tomans is defined as investment, for the second five-year development plan of the company.[6] Also, in order to realize the support of the private sector, a Research and Development Fund of Bold investing (VC) has been launched.[5] It is also possible to invest over $ 5 billion, in full capacity, in the Barakat Pharmaceutical Town.[6][5]